Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.3B | 1.4B | 1.4B | 1.3B |
Cost of revenue | 841.5M | 911.4M | 936.6M | 862.5M |
Gross profit | 409.4M | 454.0M | 459.5M | 435.0M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 313.7M | 321.8M | 305.2M | 309.5M |
Other operating expenses | — | — | — | — |
Operating income | 51.5M | 84.3M | 112.9M | 86.2M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 19.3M | 21.1M | 22.2M | 20.5M |
Other income expense | -12.1M | 6.1M | 13.4M | -2.2M |
Pretax income | 20.1M | 69.3M | 104.1M | 63.5M |
Tax provision | 6M | 19.2M | 26.4M | 18.6M |
Net income | 14.1M | 50.2M | 77.8M | 44.9M |
Basic EPS | 0.1 | 0.7 | 1.3 | 0.8 |
Diluted EPS | 0.1 | 0.7 | 1.3 | 0.8 |
Basic average shares | 51.6M | 51.4M | 51.3M | 51.2M |
Diluted average shares | 51.9M | 51.9M | 51.6M | 51.3M |
EBITDA | 95.8M | 133.0M | 154.7M | 125.6M |
Net income from continuing op. | 14.1M | 50.2M | 77.8M | 44.9M |
Minority interests | -11.3M | -17.7M | -17.2M | -9.9M |
Preferred stock dividends | — | — | — | — |